Daniel Lochner - Nov 1, 2021 Form 4 Insider Report for Oyster Point Pharma, Inc. (OYST)

Signature
/s/ Brandon Fenn, Attorney-in-Fact
Stock symbol
OYST
Transactions as of
Nov 1, 2021
Transactions value $
$98,871
Form type
4
Date filed
11/2/2021, 05:49 PM
Previous filing
Sep 7, 2021
Next filing
Jan 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OYST Common Stock Options Exercise $98.9K +8.59K +17.31% $11.51 58.2K Nov 1, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OYST Employee Stock Option (Right to Buy) Options Exercise $0 -8.59K -5.06% $0.00 161K Nov 1, 2021 Common Stock 8.59K $11.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option was granted on July 25, 2019 under the Oyster Point Pharma, Inc. 2016 Equity Incentive Plan. One quarter of the total number of shares subject to the option vested on July 22, 2020, and one forty-eighth of the total number of shares continue to vest monthly thereafter, subject to continued service to the Issuer through each such vesting date. The award is subject to vesting acceleration under certain circumstances.